Geron (GERN) Stock Forecast, Price Target & Predictions
GERN Stock Forecast
Geron stock forecast is as follows: an average price target of $6.13 (represents a 44.24% upside from GERN’s last price of $4.25) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
GERN Price Target
The average price target for Geron (GERN) is $6.13 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $4.50. This represents a potential 44.24% upside from GERN's last price of $4.25.
GERN Analyst Ratings
According to 7 Wall Street analysts, Geron's rating consensus is 'Buy'. The analyst rating breakdown for GERN stock is 0 'Strong Buy' (0.00%), 6 'Buy' (85.71%), 1 'Hold' (14.29%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Geron Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 05, 2024 | Emily Bodnar | H.C. Wainwright | $8.00 | $4.24 | 88.68% | 88.24% |
| Oct 22, 2024 | Kalpit Patel | B.Riley Financial | $5.50 | $3.95 | 39.24% | 29.41% |
| Sep 09, 2024 | Faisal Khurshid | Leerink Partners | $7.00 | $4.25 | 64.71% | 64.71% |
| Jun 10, 2024 | Corinne Jenkins | Goldman Sachs | $6.00 | $4.95 | 21.33% | 41.18% |
| Jun 10, 2024 | Stephen Willey | Stifel Nicolaus | $7.00 | $4.59 | 52.51% | 64.71% |
| Apr 30, 2024 | Joel Beatty | Robert W. Baird | $4.50 | $4.14 | 8.70% | 5.88% |
| Mar 15, 2024 | Gil Blum | Needham | $5.00 | $3.36 | 48.81% | 17.65% |
| Mar 15, 2024 | Corinne Jenkins | Goldman Sachs | $5.00 | $3.36 | 48.81% | 17.65% |
| Jan 09, 2023 | - | Needham | $4.00 | $2.79 | 43.63% | -5.88% |
| Jan 04, 2023 | - | Wedbush | $6.00 | $3.15 | 90.48% | 41.18% |
The latest Geron stock forecast, released on Nov 05, 2024 by Emily Bodnar from H.C. Wainwright, set a price target of $8.00, which represents a 88.68% increase from the stock price at the time of the forecast ($4.24), and a 88.24% increase from GERN last price ($4.25).
Geron Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 3 | 8 |
| Avg Price Target | $6.75 | $6.83 | $6.00 |
| Last Closing Price | $4.25 | $4.25 | $4.25 |
| Upside/Downside | 58.82% | 60.71% | 41.18% |
In the current month, the average price target of Geron stock is $6.75, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 58.82% increase as opposed to Geron's last price of $4.25. This month's average price target is down -1.17% compared to last quarter, and up 12.50% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 05, 2024 | H.C. Wainwright | - | Buy | Initialise |
| Oct 03, 2024 | Goldman Sachs | Buy | Buy | Hold |
| Aug 09, 2024 | B. Riley | Buy | Buy | Hold |
| Jun 10, 2024 | Goldman Sachs | Buy | Buy | Hold |
| Jun 10, 2024 | Wedbush | Buy | Buy | Hold |
| Jun 10, 2024 | Barclays | - | Overweight | Initialise |
| Jun 07, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Apr 29, 2024 | Wedbush | Buy | Buy | Hold |
| Apr 29, 2024 | Needham | Underperform | Underperform | Hold |
| Sep 12, 2023 | Goldman Sachs | Neutral | Buy | Upgrade |
Geron's last stock rating was published by H.C. Wainwright on Nov 05, 2024. The company Initialise its GERN rating from "null" to "Buy".
Geron Financial Forecast
Geron Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $164.00K | $29.00K | $21.00K | $103.00K | $297.00K | $73.00K | $123.00K | $1.04M | $109.00K | $107.00K | $137.00K | $50.00K | $108.00K | $43.00K | $52.00K | $171.00K | $131.00K | $101.00K | $57.00K | $208.00K | $537.00K |
| Avg Forecast | $81.67M | $69.11M | $58.60M | $48.61M | $37.40M | $18.97M | $344.80K | $28.83K | $81.50K | $59.00K | $66.00K | $70.00K | $124.50K | $87.17K | $114.60K | $102.25K | $77.25K | $101.75K | $83.33K | $62.50K | $70.00K | $77.00K | $55.60K | $53.50K | $73.20K | $50.00K | $100.33K | $142.67K | $210.00K | $540.00K |
| High Forecast | $81.67M | $69.11M | $58.60M | $48.61M | $37.40M | $19.98M | $344.90K | $28.92K | $87.32K | $59.00K | $66.00K | $70.00K | $124.50K | $87.17K | $114.60K | $102.25K | $77.25K | $101.75K | $83.33K | $62.50K | $70.00K | $77.00K | $55.60K | $53.50K | $73.20K | $50.00K | $100.33K | $142.67K | $252.00K | $648.00K |
| Low Forecast | $81.67M | $69.11M | $58.60M | $48.61M | $37.40M | $18.29M | $344.70K | $28.75K | $75.68K | $59.00K | $66.00K | $70.00K | $124.50K | $87.17K | $114.60K | $102.25K | $77.25K | $101.75K | $83.33K | $62.50K | $70.00K | $77.00K | $55.60K | $53.50K | $73.20K | $50.00K | $100.33K | $142.67K | $168.00K | $432.00K |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 | 7 |
| Surprise % | - | - | - | - | - | - | - | - | - | 2.78% | 0.44% | 0.30% | 0.83% | 3.41% | 0.64% | 1.20% | 13.46% | 1.07% | 1.28% | 2.19% | 0.71% | 1.40% | 0.77% | 0.97% | 2.34% | 2.62% | 1.01% | 0.40% | 0.99% | 0.99% |
Geron's average Quarter revenue forecast for Dec 23 based on 3 analysts is $81.50K, with a low forecast of $75.68K, and a high forecast of $87.32K. GERN's average Quarter revenue forecast represents a -50.30% decrease compared to the company's last Quarter revenue of $164.00K (Sep 23).
Geron EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 | 7 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-47.61M | $-51.95M | $-36.20M | $-40.63M | $-39.23M | $-26.32M | $-28.42M | $-30.66M | $-25.45M | $-28.58M | $-26.90M | $-22.87M | $-19.51M | $-15.46M | $-16.08M | $-28.33M | $-15.17M | $-14.23M | $-10.04M | $-6.92M | $-7.14M |
| Avg Forecast | $-81.67M | $-69.11M | $-58.60M | $-48.61M | $-37.40M | $-18.97M | $-344.80K | $-43.50M | $-81.50K | $-59.00K | $-66.00K | $-39.55M | $-7.88M | $-87.17K | $-114.60K | $-31.26M | $-77.25K | $-101.75K | $-83.33K | $-23.54M | $-70.00K | $-77.00K | $-55.60K | $-21.45M | $-73.20K | $-50.00K | $-100.33K | $-12.91M | $-6.92M | $-7.14M |
| High Forecast | $-81.67M | $-69.11M | $-58.60M | $-48.61M | $-37.40M | $-18.29M | $-344.70K | $-34.80M | $-75.68K | $-59.00K | $-66.00K | $-31.64M | $-6.31M | $-87.17K | $-114.60K | $-25.01M | $-77.25K | $-101.75K | $-83.33K | $-18.83M | $-70.00K | $-77.00K | $-55.60K | $-17.16M | $-73.20K | $-50.00K | $-100.33K | $-10.33M | $-5.54M | $-5.71M |
| Low Forecast | $-81.67M | $-69.11M | $-58.60M | $-48.61M | $-37.40M | $-19.98M | $-344.90K | $-52.20M | $-87.32K | $-59.00K | $-66.00K | $-47.46M | $-9.46M | $-87.17K | $-114.60K | $-37.52M | $-77.25K | $-101.75K | $-83.33K | $-28.25M | $-70.00K | $-77.00K | $-55.60K | $-25.73M | $-73.20K | $-50.00K | $-100.33K | $-15.50M | $-8.30M | $-8.57M |
| Surprise % | - | - | - | - | - | - | - | - | - | 806.98% | 787.14% | 0.92% | 5.15% | 450.10% | 229.67% | 0.91% | 396.84% | 250.11% | 343.00% | 1.14% | 326.76% | 253.42% | 277.97% | 0.75% | 387.01% | 303.42% | 141.81% | 0.78% | 1.00% | 1.00% |
undefined analysts predict GERN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Geron's previous annual EBITDA (undefined) of $NaN.
Geron Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 | 7 |
| Net Income | - | - | - | - | - | - | - | - | - | $-44.80M | $-49.23M | $-38.07M | $-42.41M | $-40.83M | $-28.26M | $-31.52M | $-33.15M | $-26.70M | $-29.57M | $-27.82M | $-23.79M | $-19.65M | $-15.82M | $-16.36M | $-29.07M | $-15.18M | $-14.24M | $-10.06M | $-6.93M | $-7.18M |
| Avg Forecast | $-13.08M | $-20.92M | $-27.25M | $-38.14M | $-42.60M | $-54.88M | $-67.36M | $-46.07M | $-68.66M | $-63.21M | $-54.49M | $-41.88M | $-7.92M | $-61.03M | $-61.47M | $-33.11M | $-54.93M | $-57.54M | $-56.24M | $-24.35M | $-42.50M | $-37.05M | $-40.54M | $-21.81M | $-133.40M | $-101.36M | $-58.85M | $-12.93M | $-6.93M | $-7.18M |
| High Forecast | $-13.08M | $-20.92M | $-27.25M | $-38.14M | $-42.60M | $-48.78M | $-67.36M | $-36.86M | $-61.79M | $-63.21M | $-54.49M | $-33.51M | $-6.33M | $-61.03M | $-61.47M | $-26.49M | $-54.93M | $-57.54M | $-56.24M | $-19.48M | $-42.50M | $-37.05M | $-40.54M | $-17.45M | $-133.40M | $-101.36M | $-58.85M | $-10.35M | $-5.55M | $-5.75M |
| Low Forecast | $-13.08M | $-20.92M | $-27.25M | $-38.14M | $-42.60M | $-60.97M | $-67.36M | $-55.28M | $-68.66M | $-63.21M | $-54.49M | $-50.26M | $-9.50M | $-61.03M | $-61.47M | $-39.73M | $-54.93M | $-57.54M | $-56.24M | $-29.22M | $-42.50M | $-37.05M | $-40.54M | $-26.17M | $-133.40M | $-101.36M | $-58.85M | $-15.52M | $-8.32M | $-8.62M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.71% | 0.90% | 0.91% | 5.36% | 0.67% | 0.46% | 0.95% | 0.60% | 0.46% | 0.53% | 1.14% | 0.56% | 0.53% | 0.39% | 0.75% | 0.22% | 0.15% | 0.24% | 0.78% | 1.00% | 1.00% |
Geron's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. GERN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Geron SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 | 7 |
| SG&A | - | - | - | - | - | - | - | - | - | $18.35M | $16.49M | $12.89M | $13.84M | $15.64M | $7.44M | $6.70M | $7.87M | $7.26M | $7.06M | $7.48M | $7.09M | $6.51M | $5.96M | $6.12M | $5.26M | $4.99M | $5.19M | $5.45M | $4.25M | $4.66M |
| Avg Forecast | $8.64B | $7.31B | $6.20B | $5.14B | $3.96B | $2.01B | $36.46M | $3.05M | $8.62M | $6.24M | $6.98M | $7.40M | $13.17M | $9.22M | $12.12M | $10.81M | $8.17M | $10.76M | $8.81M | $6.61M | $7.40M | $8.14M | $5.88M | $5.66M | $7.74M | $5.29M | $10.61M | $15.09M | $22.21M | $57.11M |
| High Forecast | $8.64B | $7.31B | $6.20B | $5.14B | $3.96B | $2.11B | $36.47M | $3.06M | $9.23M | $6.24M | $6.98M | $7.40M | $13.17M | $9.22M | $12.12M | $10.81M | $8.17M | $10.76M | $8.81M | $6.61M | $7.40M | $8.14M | $5.88M | $5.66M | $7.74M | $5.29M | $10.61M | $15.09M | $26.65M | $68.53M |
| Low Forecast | $8.64B | $7.31B | $6.20B | $5.14B | $3.96B | $1.93B | $36.45M | $3.04M | $8.00M | $6.24M | $6.98M | $7.40M | $13.17M | $9.22M | $12.12M | $10.81M | $8.17M | $10.76M | $8.81M | $6.61M | $7.40M | $8.14M | $5.88M | $5.66M | $7.74M | $5.29M | $10.61M | $15.09M | $17.77M | $45.68M |
| Surprise % | - | - | - | - | - | - | - | - | - | 2.94% | 2.36% | 1.74% | 1.05% | 1.70% | 0.61% | 0.62% | 0.96% | 0.67% | 0.80% | 1.13% | 0.96% | 0.80% | 1.01% | 1.08% | 0.68% | 0.94% | 0.49% | 0.36% | 0.19% | 0.08% |
Geron's average Quarter SG&A projection for Dec 23 is $8.62M, based on 3 Wall Street analysts, with a range of $8.00M to $9.23M. The forecast indicates a -53.03% fall compared to GERN last annual SG&A of $18.35M (Sep 23).
Geron EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 6 | 3 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 | 7 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.00 | $-0.00 | $-0.07 | $-0.10 | $-0.10 | $-0.07 | $-0.09 | $-0.10 | $-0.08 | $-0.09 | $-0.09 | $-0.07 | $-0.06 | $-0.06 | $-0.08 | $-0.15 | $-0.08 | $-0.08 | $-0.05 | $-0.04 | $-0.05 |
| Avg Forecast | $-0.02 | $-0.03 | $-0.04 | $-0.06 | $-0.07 | $-0.08 | $-0.10 | $-0.10 | $-0.10 | $-0.10 | $-0.08 | $-0.10 | $-0.12 | $-0.09 | $-0.09 | $-0.10 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.06 | $-0.06 | $-0.12 | $-0.20 | $-0.15 | $-0.09 | $-0.07 | $-0.04 | $-0.05 |
| High Forecast | $-0.02 | $-0.03 | $-0.04 | $-0.06 | $-0.07 | $-0.07 | $-0.10 | $-0.10 | $-0.09 | $-0.10 | $-0.08 | $-0.10 | $-0.12 | $-0.09 | $-0.09 | $-0.10 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.06 | $-0.06 | $-0.12 | $-0.20 | $-0.15 | $-0.09 | $-0.07 | $-0.03 | $-0.04 |
| Low Forecast | $-0.02 | $-0.03 | $-0.04 | $-0.06 | $-0.07 | $-0.09 | $-0.10 | $-0.10 | $-0.10 | $-0.10 | $-0.08 | $-0.10 | $-0.12 | $-0.09 | $-0.09 | $-0.10 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.06 | $-0.06 | $-0.12 | $-0.20 | $-0.15 | $-0.09 | $-0.07 | $-0.05 | $-0.06 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.00% | 0.00% | 0.70% | 0.81% | 1.07% | 0.74% | 0.93% | 1.19% | 0.91% | 1.05% | 1.15% | 1.08% | 1.06% | 0.97% | 0.67% | 0.74% | 0.52% | 0.89% | 0.75% | 1.00% | 1.00% |
According to undefined Wall Street analysts, Geron's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to GERN previous annual EPS of $NaN (undefined).
Geron Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals | $0.62 | $70.00 | 11190.32% | Buy |
| ELEV | Elevation Oncology | $0.65 | $9.00 | 1284.62% | Buy |
| XFOR | X4 Pharmaceuticals | $0.62 | $3.67 | 491.94% | Buy |
| IMMX | Immix Biopharma | $1.86 | $7.00 | 276.34% | Buy |
| PDSB | PDS Bio | $3.29 | $9.00 | 173.56% | Buy |
| ZURA | Zura Bio | $4.58 | $10.00 | 118.34% | Buy |
| VKTX | Viking Therapeutics | $68.48 | $102.40 | 49.53% | Buy |
| GERN | Geron | $4.25 | $6.13 | 44.24% | Buy |
| SRPT | Sarepta Therapeutics | $121.61 | $169.06 | 39.02% | Buy |
| PTCT | PTC Therapeutics | $44.28 | $46.50 | 5.01% | Hold |
| EFTR | eFFECTOR Therapeutics | - | $5.50 | - | Buy |
| TGTX | TG Therapeutics | $28.81 | $27.60 | -4.20% | Buy |
| MDGL | Madrigal Pharmaceuticals | $350.70 | $315.75 | -9.97% | Buy |
GERN Forecast FAQ
Is Geron a good buy?
Yes, according to 7 Wall Street analysts, Geron (GERN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 85.71% of GERN's total ratings.
What is GERN's price target?
Geron (GERN) average price target is $6.13 with a range of $4.5 to $8, implying a 44.24% from its last price of $4.25. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Geron stock go up soon?
According to Wall Street analysts' prediction for GERN stock, the company can go up by 44.24% (from the last price of $4.25 to the average price target of $6.13), up by 88.24% based on the highest stock price target, and up by 5.88% based on the lowest stock price target.
Can Geron stock reach $6?
GERN's average twelve months analyst stock price target of $6.13 supports the claim that Geron can reach $6 in the near future.
What is Geron's current price target trend?
2 Wall Street analysts forecast a $6.75 price target for Geron (GERN) this month, up 58.82% from its last price of $4.25. Compared to the last 3 and 12 months, the average price target increased by 60.71% and increased by 41.18%, respectively.
What are Geron's analysts' financial forecasts?
Geron's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $56.75M (high $57.75M, low $56.07M), average EBITDA is $-100M (high $-90.839M, low $-110M), average net income is $-211M (high $-196M, low $-226M), average SG&A $6B (high $6.11B, low $5.93B), and average EPS is $-0.348 (high $-0.338, low $-0.357). GERN's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $257.99M (high $257.99M, low $257.99M), average EBITDA is $-258M (high $-258M, low $-258M), average net income is $-99.394M (high $-99.394M, low $-99.394M), average SG&A $27.28B (high $27.28B, low $27.28B), and average EPS is $-0.152 (high $-0.152, low $-0.152).
Did the GERN's actual financial results beat the analysts' financial forecasts?
Based on Geron's last annual report (Dec 2022), the company's revenue was $596K, beating the average analysts forecast of $428.52K by 39.08%. Apple's EBITDA was $-135M, beating the average prediction of $-39.348M by 243.14%. The company's net income was $-141M, missing the average estimation of $-164M by -13.75%. Apple's SG&A was $43.63M, missing the average forecast of $45.32M by -3.73%. Lastly, the company's EPS was $-0.37, missing the average prediction of $-0.413 by -10.34%. In terms of the last quarterly report (Sep 2023), Geron's revenue was $164K, beating the average analysts' forecast of $59K by 177.97%. The company's EBITDA was $-47.612M, beating the average prediction of $-59K by 80598.31%. Geron's net income was $-44.805M, missing the average estimation of $-63.211M by -29.12%. The company's SG&A was $18.35M, beating the average forecast of $6.24M by 194.10%. Lastly, the company's EPS was $-0.0001, missing the average prediction of $-0.0967 by -99.90%